Site identity card

Bicêtre Hospital

Le Kremlin-Bicêtre, France
Share

Networks

Clinical Studies (2)

  • COMEBAC 2 : Study aims to determine the prevalence of persistent respiratory symptoms or residual respiratory complaints after hospitalisation for COVID-19 during the second wave in France
  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to